Tofacitinib as an alternative therapy for refractory intestinal Behçet's syndrome.
Ther Adv Musculoskelet Dis
; 14: 1759720X221124014, 2022.
Article
in En
| MEDLINE
| ID: mdl-36171803
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Ther Adv Musculoskelet Dis
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
Reino Unido